Active, not recruitingPhase 1NCT04533750
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Studying Squamous cell carcinoma of oral cavity and lip
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Maura L GillisonNRG Oncology
- Intervention
- Computed Tomography(procedure)
- Enrollment
- 21 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2026
Study locations (27)
- Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
- Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States
- Banner University Medical Center - Tucson, Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States
- UC San Diego Moores Cancer Center, La Jolla, California, United States
- Stanford Cancer Institute Palo Alto, Palo Alto, California, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
- Moffitt Cancer Center, Tampa, Florida, United States
- Emory University Hospital Midtown, Atlanta, Georgia, United States
- Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
- Carle at The Riverfront, Danville, Illinois, United States
- Carle Physician Group-Effingham, Effingham, Illinois, United States
- Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States
- Carle Cancer Center, Urbana, Illinois, United States
- The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States
- +12 more locations on ClinicalTrials.gov
Collaborators
NRG Oncology
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04533750 on ClinicalTrials.govOther trials for Squamous cell carcinoma of oral cavity and lip
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07195734Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck CancerNational Cancer Institute (NCI)
- RECRUITINGNANCT07264036Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot StudyVanessa Torrecillas
- RECRUITINGPHASE2NCT07121595Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT TrialUniversity of Michigan Rogel Cancer Center
- RECRUITINGNCT05837221Microbiome in Head and Neck Squamous Cell CarcinomaUniversity of Colorado, Denver
- RECRUITINGPHASE2NCT05576974A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)University of Texas Southwestern Medical Center
- RECRUITINGPHASE1, PHASE2NCT06265025GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid TumorsGeneMedicine Co., Ltd.
- RECRUITINGNANCT05811936The SNAP Tool for Head and Neck Cancer Survivor-Caregiver DyadsMedical University of South Carolina
- ACTIVE NOT RECRUITINGPHASE1NCT05820711Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation TherapyUniversity of Wisconsin, Madison
See all trials for Squamous cell carcinoma of oral cavity and lip →